Cytotoxicity of a transferrin‐adriamycin conjugate to anthracycline‐resistant cells

International Journal of Cancer

Volumn 52, Issue 4, 1992, Pages 619-623

  Fritzer, Monika ^a   Barabas, Klara ^a,b   Szüts, Viktoria ^b   Berczi, Alajos ^b   Szekeres, Thomas ^a   Faulk, W Page ^c   Goldenberg, Hans ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; DOXORUBICIN CONJUGATE; TRANSFERRIN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HL 60; CELL STRAIN K 562; CONTROLLED STUDY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG RESISTANCE; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

DOXORUBICIN; DRUG RESISTANCE; HUMAN; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; SUPPORT, NON-U.S. GOV'T; TRANSFERRIN; TUMOR CELLS, CULTURED;

EID: 0026775361     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910520421     Document Type: Article

References (34)

1. Evidence in support of the plasma membrane as the target for transferrin‐Adriamycin conjugates in K562 cells
2. Adriamycin (hydrazone)‐Antibody conjugates require internalization and intracellular hydrolysis for antitumor activity
3. Contimuous growth and differentiation of human myeloid leukaemic cells in suspension culture
4. Superiority of an acid‐Labile daunorubicin‐Monoclonal antibody conjugate compared to free drug
5. Transferrinadriamycin conjugates which inhibit tumor cell proliferation without interaction with DNA inhibit plasma membrane oxidoreductase and proton release in K562 cells
6. Transferrin receptor growth control in normal and transformed cells
7. Recent advances in cancer research—drug targeting without the use of monoclonal antibodies
8. Transferrin and transferrin receptors in carcinoma of the breast
9. Preliminary clinical study of transferrin‐Adriamycin conjugate for drug delivery to acute leukemia patients
10. Different distribution of daunomycin in plasma membranes from drug‐Sensitive and drug‐Resistant P388‐Leukemia cells
11. Comparison of the membrane transport of anthracycline derivatives in drug‐Resistant and drug‐Sensitive K562 cells
12. Transferrin binding by human lymphoblastoid cell lines and other transformed cells
13. Correlation between growth inhibition and intranuclear doxorubicin and 4′‐Deoxy‐4′‐Iododoxorubicin quantitated in living K562 cells by microspectrofluorometry
14. Induction of erythroid differentiation in human leukemic K562 cells, by membrane‐Directed action of adriamycin covalently bound to microspheres
15. Binding of apotransferrin to K562 cells: explanation of the transferrin cycle
16. Kinetics of internalization and cytotoxicity of transferrinneocarzinostatin conjugate in human leukemia cell line, K562
17. Human chronic myelogenous leukemic cell line with positive Philadelphia chromosome
18. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays
19. Characterization of a transferrin‐Diphtheria toxin conjugate
20. Multiple‐Drug resistance in human cancer
21. A highly cytotoxic human transferrin‐Ricin A chain conjugate used to select receptor modified cells
22. Electron spin resonance study on the mode of generation of free radicals of daunomycin, adriamycin and carboquone in NAD(p)h‐Microsome system
23. Anthracycline immunoconjugates prepared by a site‐Specific linkage via an amino‐Dextran intermediate carrier
24. +‐ATPase regulation of endosomal acidification in K562 erythroleukemia cells—analysis via inhibition of transferrin recycling by low temperatures
25. Kinetic parameters for the uptake of anthracycline by drug‐Resistant and drug‐Sensitive K562 cells
26. Cell surface actions of adriamycin
27. Anti‐Transferrin receptor monoclonal antibody and toxin antibody conjugates affect growth of human tumour cells
28. Fatty acid composition, transport and metabolism in doxorubicin‐Sensitive and ‐Resistant rat glioblastoma cells
29. DMA‐Modification and cancer
30. Uptake and concentration of bioactive macromolecules by K562 cells via the transferrin cycle utilizing an acid‐Labile transferrin conjugate
31. Cell surface effects of adriamycin and carminomycin immobilized on cross‐Linked polyvinyl alcohol
32. Killing of human tumor cells in culture with adriamycin conjugates of human transferrin
33. Loss of transferrin receptors following induced differentiation of HL‐60 promyelocytic leukemia cells
34. Targeting of cytotoxic drugs by transferrin receptors: selective killing of acute myelogenous leukemia cells